HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qian Li Selected Research

4-(5-naphthyl-3- (trifluoromethyl)- 1H- pyrazol- 1- yl)benzenesulfonamide

12/2009PC-407, a celecoxib derivative, inhibited the growth of colorectal tumor in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qian Li Research Topics

Disease

403Neoplasms (Cancer)
07/2022 - 05/2004
108Inflammation (Inflammations)
11/2022 - 09/2004
78Neoplasm Metastasis (Metastasis)
06/2022 - 07/2004
68Infections
03/2022 - 09/2003
67Breast Neoplasms (Breast Cancer)
11/2022 - 08/2009
52Carcinogenesis
01/2022 - 08/2007
49Hypoxia (Hypoxemia)
11/2022 - 02/2006
49Type 2 Diabetes Mellitus (MODY)
01/2022 - 07/2009
43Stomach Neoplasms (Stomach Cancer)
06/2022 - 12/2008
43Hepatocellular Carcinoma (Hepatoma)
04/2022 - 04/2009
42Fibrosis (Cirrhosis)
01/2022 - 01/2004
35Pain (Aches)
02/2022 - 11/2003
33Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 08/2007
33Insulin Resistance
01/2022 - 05/2010
33Ischemia
01/2021 - 07/2006
26Reperfusion Injury
01/2022 - 07/2006
26Obesity
01/2022 - 02/2011
25Carcinoma (Carcinomatosis)
04/2022 - 01/2010
24COVID-19
11/2022 - 01/2020
24Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2013
24Lung Neoplasms (Lung Cancer)
01/2022 - 11/2011
24Hypertension (High Blood Pressure)
01/2022 - 03/2012
23Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 11/2011
22Body Weight (Weight, Body)
01/2022 - 01/2007
21Neuroinflammatory Diseases
11/2022 - 08/2014
21Colonic Neoplasms (Colon Cancer)
01/2022 - 08/2007
21Hyperglycemia
01/2022 - 08/2004
20Alzheimer Disease (Alzheimer's Disease)
09/2022 - 09/2004
20Wounds and Injuries (Trauma)
01/2022 - 01/2013
19Necrosis
07/2022 - 03/2008
19Stroke (Strokes)
01/2022 - 05/2009
19Lung Injury
01/2022 - 05/2012
18Melanoma (Melanoma, Malignant)
06/2022 - 01/2016
18Sepsis (Septicemia)
03/2022 - 07/2010
18Atherosclerosis
01/2022 - 04/2007
18Adenocarcinoma
10/2021 - 09/2012
16Asthma (Bronchial Asthma)
04/2022 - 01/2009
16Myocardial Infarction
01/2022 - 07/2011
15Gestational Diabetes (Gestational Diabetes Mellitus)
07/2022 - 09/2015
15Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 01/2010
15Acute Lung Injury
04/2021 - 10/2007
14Ischemic Stroke
01/2022 - 08/2010
14Brain Ischemia (Cerebral Ischemia)
01/2022 - 07/2006
14Hyperalgesia
12/2021 - 01/2012
13Multiple Myeloma
12/2022 - 02/2010
13Hemorrhage
05/2022 - 01/2014
13Colitis
04/2022 - 12/2009
13Cognitive Dysfunction
04/2022 - 09/2004
13Adenocarcinoma of Lung
03/2022 - 11/2015
13Hypersensitivity (Allergy)
02/2022 - 04/2005
13Neuralgia (Stump Neuralgia)
02/2022 - 01/2012
13Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 09/2015
13Nasopharyngeal Carcinoma
01/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

168Proteins (Proteins, Gene)FDA Link
11/2022 - 09/2004
88Biomarkers (Surrogate Marker)IBA
12/2022 - 04/2009
72Pharmaceutical PreparationsIBA
05/2022 - 01/2008
67MicroRNAs (MicroRNA)IBA
03/2022 - 12/2011
59CytokinesIBA
10/2022 - 08/2010
57Biological ProductsIBA
01/2022 - 01/2007
54Long Noncoding RNAIBA
03/2022 - 07/2015
48Glucose (Dextrose)FDA LinkGeneric
05/2022 - 08/2004
48Messenger RNA (mRNA)IBA
01/2022 - 09/2008
40DNA (Deoxyribonucleic Acid)IBA
04/2022 - 01/2007
34RNA (Ribonucleic Acid)IBA
11/2022 - 04/2006
34Insulin (Novolin)FDA Link
01/2022 - 07/2009
30LipidsIBA
06/2022 - 11/2007
29VaccinesIBA
01/2022 - 02/2005
28Interleukin-6 (Interleukin 6)IBA
11/2022 - 10/2007
27Peptides (Polypeptides)IBA
01/2022 - 09/2005
26EnzymesIBA
01/2022 - 05/2010
24Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2022 - 04/2015
23Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022 - 09/2010
23Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 11/2009
22LipopolysaccharidesIBA
01/2022 - 08/2007
21Therapeutic UsesIBA
09/2022 - 08/2008
21Small Interfering RNA (siRNA)IBA
01/2022 - 08/2008
20AntioxidantsIBA
05/2022 - 05/2012
20Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 10/2007
19CholesterolIBA
10/2022 - 06/2005
18CateninsIBA
05/2021 - 08/2011
17Circular RNAIBA
07/2022 - 01/2018
17AntibodiesIBA
01/2022 - 10/2008
17Oxygen (Dioxygen)IBA
11/2020 - 02/2006
15HydrogelsIBA
04/2022 - 05/2018
15Streptozocin (Streptozotocin)FDA Link
01/2022 - 05/2006
15Polysaccharides (Glycans)IBA
01/2022 - 08/2010
15PolyaminesIBA
02/2021 - 01/2011
14InflammasomesIBA
02/2022 - 12/2015
14Neuroprotective AgentsIBA
02/2022 - 01/2008
14AcidsIBA
01/2022 - 07/2004
13ErbB Receptors (EGF Receptor)IBA
07/2022 - 11/2010
13Retinaldehyde (Retinal)IBA
06/2022 - 03/2008
13InterferonsIBA
02/2022 - 01/2015
13CollagenIBA
01/2022 - 01/2007
13Blood Glucose (Blood Sugar)IBA
12/2021 - 06/2009

Therapy/Procedure

157Therapeutics
11/2022 - 02/2004
62Drug Therapy (Chemotherapy)
06/2022 - 01/2009
17Immunotherapy
03/2022 - 09/2019
16Radiotherapy
01/2022 - 01/2016
15Photochemotherapy (Photodynamic Therapy)
08/2021 - 07/2011